Foghorn Therapeutics, Inc. (FHTX)
2.04
+0.17
(+9.09%)
USD |
NASDAQ |
Nov 09, 16:00
2.04
0.00 (0.00%)
After-Hours: 18:30
Foghorn Therapeutics Gross Profit (Annual) : 27.58M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.58M |
| December 31, 2024 | 19.48M |
| December 31, 2023 | 25.49M |
| December 31, 2022 | 11.33M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.196M |
| December 31, 2020 | -0.897M |
| December 31, 2019 | -1.793M |
| December 31, 2018 | -0.379M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Anavex Life Sciences Corp. | 0.00 |
| Vaxcyte, Inc. | -24.86M |
| Connect Biopharma Holdings Ltd. | 0.00 |
| Caribou Biosciences, Inc. | 7.514M |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |